Posted to MedZilla on 5/25/2017

Takeda Pharmaceuticals

US-MA, Associate Director, Microbiome Research, GI DDU 1601253-MZ



Based in Cambridge, MA, the role is a research leader in the area of Gastroenterological (GI) Disease with a focus on microbiome research and external innovation. Responsible for identifying opportunities within local, national and international centers of excellence for novel microbiome-related approaches to the treatment of GI disorders. Leads research projects in collaboration with external partners.


  • As a scientific research leader within the Gastrointestinal Drug Discovery Unit, will be working within a highly matrixed & virtual environment, contributes to building a robust preclinical and early clinical pipeline in gastroenterological diseases.
  • Plays a key role in translational research activities in partnership with Translational Research & Early Clinical research team and expert external groups
  • Identifies, establishes and ensures the success of key external collaborations targeting and developing novel microbiome therapeutic approaches to GI disorders
  • Collaborates, influences and leads cross-functional matrix teams from Research, the GI Therapeutic Area Unit, Legal, Business Development, etc.
  • Builds relationships & collaborates with scientific leaders, KOLs, academic partners, CROs and biotech companies and is seen as an international subject matter expert in GI microbiome research and therapeutics.
  • Responsible for oversight of local external partnerships (CRO, biotech partners, academic labs, etc.) to ensure milestones, deliverables are met according to timelines and expectations of quality.
  • Seeks and proposes preclinical and clinical in licensing candidates and provides expert input to their evaluation
  • Is a member of the GI matrix team and contributes to strategic decisions to advance research projects from early stages to developmental stages in a way that maximizes the likelihood of long term success (POC and beyond).
  • Is an active member of the GI DDU leadership team, supporting the Head GI DDU to make the best use of human and financial resources.
  • Identified as a Global Takeda thought leader in microbiome and GI disease research and provides subject-matter expertise.
  • Represents Takeda and is responsible for creating a presence in GI microbiota research and related scientific community through scientific meetings, advisory boards, online research communities, etc..
  • Keeps up with the up-to-date scientific advancement (e.g. competitive situation, new technology, new research portfolio, and new partnership) and is well informed about current regulatory (FDA, EMA, etc.) requirements and trends.


  • Has an advanced degree in health or life sciences (e.g., Ph.D., M.D., D.V.M.) with proven GI microbiome research experience and accomplishment.
  • Is highly knowledgeable and experienced in aspects of microbiome research in context of GI motility and functional bowel disorders, immunology and inflammatory bowel diseases and/or liver diseases
  • Demonstrates good knowledge of drug discovery and translational research, through to early clinical research (Proof of Concept). Industry experience would be an advantage.
  • Has strong leadership skills and acumen.
  • Has excellent written and verbal communication skills in English.
  • Capable of leading a matrixed team comprised of scientists from within Takeda as well as external collaborators.

  • Requires approximately 20% or more travel, including international.

we are driven to improve people's lives

Takeda is an EEO employer of minorities, women, disabled, protected veterans. For more information, visit

No Phone Calls or Recruiters Please.



Please visit our website at


* If a direct employer requests that you go to their web site and complete your application there in order to be
  considered, please do so. Applications for all positions are subject to each employer's specific requirements.